Treatment of Bardet-Biedl-Syndrome With Metformin for Evaluation of a Possible Visual Improvement

NCT03490019 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped unrealizable wishes of national authorities

Conditions

Bardet-Biedl Syndrome
Visual Impairment

Interventions

DRUG: Metformin

Sponsor

University Hospital Tuebingen